NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and clinical researchaffiliate Lupus Therapeutics will present data at ACR Convergence 2022 showing that the pilot peer education program Patient Advocates for Lupus Studies (PALS), increased knowledge, perception, and intentions among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials. These study results (Abstract #2245) offer promise particularly for groups often underrepresented in clinical studies, including those of Black ancestry.
The full press release is available on the Lupus Therapeutics website.
Tags: ACR Convergence 2022, Albert Roy, American College of Rheumatology, Dr. Saira Sheikh, Lupus Clinical Investigators Network, lupus therapeutics, PALS, Patient Advocates for Lupus Studies, SRI-4 and BICLA